HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicolae Ghinea Selected Research

FSH Receptors (FSH Receptor)

4/2021Anti-Angiogenic Therapy: Albumin-Binding Proteins Could Mediate Mechanisms Underlying the Accumulation of Small Molecule Receptor Tyrosine Kinase Inhibitors in Normal Tissues with Potential Harmful Effects on Health.
1/2018Vascular Endothelial FSH Receptor, a Target of Interest for Cancer Therapy.
10/2017Antibody Selection for Cancer Target Validation of FSH-Receptor in Immunohistochemical Settings.
2/2015Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery.
7/2013Follicle-stimulating hormone receptor expression in soft tissue sarcomas.
5/2013Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases.
9/2012Endothelial follicle stimulating hormone receptor in primary kidney cancer correlates with subsequent response to sunitinib.
10/2010Expression of follicle-stimulating hormone receptor in tumor blood vessels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicolae Ghinea Research Topics

Disease

10Neoplasms (Cancer)
04/2021 - 10/2010
3Breast Neoplasms (Breast Cancer)
02/2015 - 12/2007
1Ovarian Neoplasms (Ovarian Cancer)
12/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2019
1Vascular Remodeling
02/2015
1Sarcoma (Soft Tissue Sarcoma)
07/2013
1Neoplasm Metastasis (Metastasis)
05/2013
1Leiomyosarcoma
05/2013
1Kidney Neoplasms (Kidney Cancer)
09/2012
1Renal Cell Carcinoma (Grawitz Tumor)
09/2012

Drug/Important Bio-Agent (IBA)

8FSH Receptors (FSH Receptor)IBA
04/2021 - 10/2010
4AntibodiesIBA
04/2021 - 10/2010
4Proteins (Proteins, Gene)FDA Link
04/2021 - 07/2013
3Phenobarbital (Luminal)FDA Link
04/2021 - 10/2010
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
04/2021 - 09/2012
2CytokinesIBA
01/2019 - 12/2007
2Monoclonal AntibodiesIBA
05/2013 - 10/2010
1Carrier Proteins (Binding Protein)IBA
04/2021
1AlbuminsIBA
04/2021
1Angiogenesis InhibitorsIBA
04/2021
1Cysteine (L-Cysteine)FDA Link
04/2021
1Drug CarriersIBA
04/2021
1Phosphotransferases (Kinase)IBA
04/2021
1tyrosine receptor (receptor, tyrosine)IBA
04/2021
1Messenger RNA (mRNA)IBA
12/2020
1Small Interfering RNA (siRNA)IBA
12/2020
1LH Receptors (LH Receptor)IBA
12/2020
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2019
1Hormones (Hormone)IBA
01/2018
1Glycoproteins (Glycoprotein)IBA
01/2018
1Humanized Monoclonal AntibodiesIBA
01/2018
1Tumor Biomarkers (Tumor Markers)IBA
12/2017
1Follicle Stimulating Hormone (Follitropin)FDA Link
10/2017
1Progesterone Receptors (Progesterone Receptor)IBA
05/2013
1Estrogen ReceptorsIBA
05/2013
1Sunitinib (Sutent)FDA Link
09/2012
1Gold Colloid (Colloidal Gold)IBA
10/2010
1LigandsIBA
10/2010
1EpitopesIBA
10/2010
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
12/2007
1VaccinesIBA
12/2007

Therapy/Procedure

4Therapeutics
04/2021 - 12/2007